Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2026-11

The present notice serves to conclude agreements with pharmaceutical companies in the sense of § 130a, paragraph 8, sentence 1, SGB V. The invitation to participate is only addressed to pharmaceutical entrepreneurs or associations of employees of pharmaceutical entrepreneurs in the sense of § 4, paragraph 18, of the Medicinal Products Act. This is not an Open Procedure in accordance with § 15 VgV in conjunction with § 119, paragraph 3, GWB, but a publication of the invitation to conclude/join discount contracts with conditions that are fixed and non-negotiable for all participants, including the level of the discount. There can be an unlimited number of contractual partners, which can be pharmaceutical entrepreneurs or associations of employees of pharmaceutical entrepreneurs in the sense of § 4, paragraph 18, of the Medicinal Products Act.